Literature DB >> 15885523

Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993.

Susanne Oksbjerg Dalton1, Lene Mellemkjaer, Lars Thomassen, Preben B Mortensen, Christoffer Johansen.   

Abstract

We investigated the cancer risk of patients hospitalized for schizophrenia in a nationwide cohort study. All 22766 adults admitted for schizophrenia, ICD-8 295, in Denmark between 1969 and 1993 were followed up for cancer through 1995. The incidence of site-specific cancers was compared with national incidence rates, adjusted for sex, age and calendar time. The risk for cancer was increased for both men and women during the first year of follow-up. When the first year of follow-up was excluded, the risk for all tobacco-associated cancers and for prostate and rectal cancers was reduced for male patients with schizophrenia. The standardized incidence ratio (SIR) of lung cancer was marginally reduced (SIR, 0.86; 95% CI: 0.65, 1.02) for male patients with schizophrenia; this was due, however, to a reduction in risk for older patients. An increased risk for breast cancer found for female patients with schizophrenia (SIR, 1.20; 95% CI: 1.05, 1.38) should be interpreted with caution, given the high proportion of nulliparous women with schizophrenia in Denmark. The data might support reduced risks for prostate and rectal cancer among male patients with schizophrenia, whereas a changing smoking pattern might explain the reduced risk for tobacco-related cancers.

Entities:  

Mesh:

Year:  2004        PMID: 15885523     DOI: 10.1016/j.schres.2004.11.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  33 in total

1.  Using the literature-based discovery paradigm to investigate drug mechanisms.

Authors:  Caroline B Ahlers; Dimitar Hristovski; Halil Kilicoglu; Thomas C Rindflesch
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

Review 2.  Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.

Authors:  Rafael Tabarés-Seisdedos; John L Rubenstein
Journal:  Nat Rev Neurosci       Date:  2013-04       Impact factor: 34.870

3.  A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.

Authors:  Lili Aslostovar; Allison L Boyd; Mohammed Almakadi; Tony J Collins; Darryl P Leong; Rommel G Tirona; Richard B Kim; Jim A Julian; Anargyros Xenocostas; Brian Leber; Mark N Levine; Ronan Foley; Mickie Bhatia
Journal:  Blood Adv       Date:  2018-08-14

4.  Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis.

Authors:  Chuanjun Zhuo; Patrick Todd Triplett
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

5.  Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.

Authors:  Gen-Min Lin; Yu-Jung Chen; De-Jhen Kuo; Lamin E S Jaiteh; Yi-Chung Wu; Tzu-Shun Lo; Yi-Hwei Li
Journal:  Schizophr Bull       Date:  2011-11-01       Impact factor: 9.306

6.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

7.  Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden.

Authors:  Jianguang Ji; Kristina Sundquist; Yi Ning; Kenneth S Kendler; Jan Sundquist; Xiangning Chen
Journal:  Schizophr Bull       Date:  2012-04-20       Impact factor: 9.306

8.  Is Schizophrenia a Risk Factor for Breast Cancer?-Evidence From Genetic Data.

Authors:  Enda M Byrne; Manuel A R Ferreira; Angli Xue; Sara Lindström; Xia Jiang; Jian Yang; Douglas F Easton; Naomi R Wray; Georgia Chenevix-Trench
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

9.  Cancer comortality patterns in schizophrenia and psychotic disorders: a new methodological approach for unique databases.

Authors:  Vladeta Ajdacic-Gross; Alois Tschopp; Matthias Bopp; Felix Gutzwiller; Wulf Rössler
Journal:  Int J Methods Psychiatr Res       Date:  2014-01-28       Impact factor: 4.035

10.  DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.

Authors:  Min Yong; Tinghe Yu; Si Tian; Shuaibin Liu; Jiao Xu; Jianguo Hu; Lina Hu
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.